News

$5.5 million for cellvie

Cellvie is developing medicines from cells, leveraging the therapeutic potential of mitochondria, commonly known as the powerhouses of the cell. The fresh capital will be employed to accelerate the development of the company’s technology platform, strengthen the team, and further establish mitochondria manufacturing.

weiterlesen

IMD Startup Competition reveals the 2022/2023 winners

The selection round for the 25th annual IMD Startup Competition has closed after the jury selected 30 startups from various sectors to work with the MBA and EMBA classes of 2023. The first program kicks off in January with the MBA class.  One of them is the Technopark Zurich resident matchspace.

weiterlesen